SAN DIEGO--(BUSINESS WIRE)--Nielsen BioSciences, Inc. (“Nielsen”), a privately-held, San Diego-based biopharmaceutical company, announced the final patient has been successfully enrolled in CFW-3A – A ...
I always recommend candida albicans skin antigen test injections for patients who are not responding well to liquid nitrogen +/- paring for verruca vulgaris. A 0.1-mg injection every month for about 3 ...
SAN DIEGO--(BUSINESS WIRE)--Nielsen BioSciences, Inc. (“Nielsen”), a privately-held, San Diego-based biopharmaceutical company, today announced the first patient enrolled in CFW-3A – a Phase 3, ...
Carol A Kumamoto receives funding for research from the National Institutes of Health (AI118898). Jesus A. Romo receives funding from the National Institutes of Health (T32AI007329). He is a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback